RXL holdings
All 68 positions of ProShares Ultra Health Care. as of Oct 26, 2026issuer data
Positions
68
Top 10 weight
161.1%
Effective holdings
8.7
1 / sum of squared weights
In stocks
64.5%
In bonds
0.0%
Outside the US
0.0%
Asset mix
Sectors
100% of stocks classifiedCountries
Holdings
as of Oct 26, 2026issuer data| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | HEALTH CARE SELECT SECTOR INDEX SWAP UBS AG | Derivative | 43.87% | $46M | 25,402 | |
| 2 | HEALTH CARE SELECT SECTOR INDEX SWAP BNP PARIBAS | Derivative | 38.26% | $40M | 22,151 | |
| 3 | HEALTH CARE SELECT SECTOR INDEX SWAP CITIBANK NA | Derivative | 22.52% | $24M | 13,041 | |
| 4 | Net Other Assets (Liabilities) | Cash | 21.21% | $22M | 22,249,014 | |
| 5 | HEALTH CARE SELECT SECTOR INDEX SWAP GOLDMAN SACHS INTERNATIONAL | Derivative | 17.09% | $18M | 9,896 | |
| 6 | IQMMProShares GENIUS Money Market ETF | Cash | 14.32% | $15M | 150,000 | |
| 7 | HEALTH CARE SELECT SECTOR INDEX SWAP SOCIETE GENERALE | Derivative | 10.63% | $11M | 6,152 | |
| 8 | LLYEli Lilly & Co. | Equity | 10.17% | $11M | 8,340 | US |
| 9 | JNJJohnson & Johnson | Equity | 6.38% | $6.7M | 25,122 | US |
| 10 | ABBVABBVIE INC. | Equity | 5.03% | $5.3M | 18,418 | US |
| 11 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 3.66% | $3.8M | 9,357 | US |
| 12 | MRKMerck & Co., Inc. | Equity | 3.45% | $3.6M | 25,716 | US |
| 13 | TMOThermo Fisher Scientific, Inc. | Equity | 2.52% | $2.6M | 3,852 | US |
| 14 | HEALTH CARE SELECT SECTOR INDEX SWAP BANK OF AMERICA NA | Derivative | 2.48% | $2.6M | 1,435 | |
| 15 | AMGNAmgen Inc | Equity | 2.39% | $2.5M | 5,635 | US |
| 16 | GILDGilead Sciences Inc | Equity | 1.96% | $2.1M | 12,925 | US |
| 17 | ABTAbbott Laboratories | Equity | 1.80% | $1.9M | 18,038 | US |
| 18 | PFEPfizer Inc. | Equity | 1.69% | $1.8M | 59,412 | US |
| 19 | ISRGIntuitive Surgical Inc. | Equity | 1.59% | $1.7M | 3,682 | US |
| 20 | DHRDanaher Corporation | Equity | 1.45% | $1.5M | 6,522 | US |
| 21 | VRTXVertex Pharmaceuticals Inc | Equity | 1.30% | $1.4M | 2,644 | US |
| 22 | BMYBristol-Myers Squibb Co. | Equity | 1.25% | $1.3M | 21,293 | US |
| 23 | CVSCVS HEALTH CORPORATION | Equity | 1.18% | $1.2M | 13,330 | US |
| 24 | MDTMedtronic plc | Equity | 1.15% | $1.2M | 12,770 | |
| 25 | MCKMcKesson Corporation | Equity | 1.15% | $1.2M | 1,216 | US |
| 26 | SYKStryker Corporation | Equity | 1.06% | $1.1M | 3,636 | US |
| 27 | ELVElevance Health, Inc. | Equity | 0.93% | $975K | 2,260 | US |
| 28 | CIThe Cigna Group | Equity | 0.80% | $843K | 2,756 | US |
| 29 | REGNRegeneron Pharmaceuticals Inc | Equity | 0.79% | $827K | 1,024 | US |
| 30 | MRNAModerna, Inc. Common Stock | Equity | 0.73% | $769K | 3,868 | US |
| 31 | HCAHCA Healthcare, Inc. | Equity | 0.68% | $714K | 1,535 | US |
| 32 | BSXBoston Scientific Corp. | Equity | 0.66% | $689K | 15,107 | US |
| 33 | CORCencora, Inc. | Equity | 0.63% | $657K | 1,991 | US |
| 34 | CAHCardinal Health, Inc. | Equity | 0.58% | $610K | 2,427 | US |
| 35 | BDXBecton, Dickinson and Co. | Equity | 0.53% | $558K | 2,840 | US |
| 36 | EWEdwards Lifesciences Corp | Equity | 0.52% | $544K | 6,010 | US |
| 37 | HUMHumana Inc. | Equity | 0.50% | $521K | 1,249 | US |
| 38 | AAgilent Technologies Inc. | Equity | 0.49% | $518K | 2,945 | US |
| 39 | VEEVVeeva Systems Inc. | Equity | 0.47% | $496K | 1,560 | US |
| 40 | IQVIQVIA Holdings Inc. | Equity | 0.45% | $469K | 1,715 | US |
| 41 | WATWaters Corp | Equity | 0.45% | $468K | 1,027 | US |
| 42 | IDXXIdexx Laboratories Inc | Equity | 0.45% | $467K | 819 | US |
| 43 | ILMNIllumina Inc | Equity | 0.41% | $426K | 1,571 | US |
| 44 | BIIBBiogen Inc. Common Stock | Equity | 0.37% | $389K | 1,541 | US |
| 45 | RMDResMed Inc. | Equity | 0.36% | $381K | 1,503 | US |
| 46 | CNCCentene Corporation | Equity | 0.33% | $350K | 5,151 | US |
| 47 | ZTSZOETIS INC. | Equity | 0.33% | $349K | 4,306 | US |
| 48 | MTDMettler-Toledo International | Equity | 0.33% | $347K | 208 | US |
| 49 | GEHCGE HealthCare Technologies Inc. Common Stock | Equity | 0.32% | $339K | 4,710 | US |
| 50 | DXCMDexCom, Inc. | Equity | 0.29% | $309K | 3,935 | US |
| 51 | WSTWest Pharmaceutical Services, Inc. | Equity | 0.28% | $289K | 732 | US |
| 52 | DGXQuest Diagnostics Inc. | Equity | 0.27% | $279K | 1,148 | US |
| 53 | LHLabcorp Holdings Inc. | Equity | 0.27% | $278K | 844 | US |
| 54 | STESTERIS plc | Equity | 0.22% | $234K | 1,018 | |
| 55 | VTRSViatris Inc. Common Stock | Equity | 0.21% | $219K | 11,974 | US |
| 56 | INCYIncyte Genomics Inc | Equity | 0.19% | $201K | 1,777 | US |
| 57 | ZBHZimmer Biomet Holdings, Inc. | Equity | 0.18% | $194K | 1,990 | US |
| 58 | RVTYRevvity, Inc. | Equity | 0.18% | $186K | 1,162 | US |
| 59 | CRLCharles River Laboratories International, Inc. | Equity | 0.17% | $177K | 496 | US |
| 60 | BAXBaxter International Inc. | Equity | 0.13% | $136K | 5,387 | US |
| 61 | SOLVSolventum Corporation | Equity | 0.12% | $129K | 1,508 | US |
| 62 | COOThe Cooper Companies, Inc. Common Stock | Equity | 0.12% | $124K | 2,032 | US |
| 63 | TECHBio-Techne Corp. | Equity | 0.11% | $119K | 1,632 | US |
| 64 | PODDInsulet Corporation | Equity | 0.10% | $108K | 721 | US |
| 65 | ALGNAlign Technology Inc | Equity | 0.10% | $105K | 690 | US |
| 66 | UHSUniversal Health Services, Inc. Class B | Equity | 0.10% | $100K | 539 | US |
| 67 | HSICHenry Schein Inc | Equity | 0.08% | $85K | 1,000 | US |
| 68 | DVADaVita Inc. | Equity | 0.06% | $65K | 354 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| New position | VEEVVeeva Systems, Inc. | — | 0.38% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | HOLXHologic, Inc. | 0.21% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | MOHMolina Healthcare, Inc. | 0.10% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.